Cite
HARVARD Citation
Stringhini, M. et al. (2020). Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response of tissue‐resident memory T cells against the AH1 rejection antigen. European journal of immunology. 50 (10), pp. 1591-1597. [Online].